Literature DB >> 35783997

Assessment of Risk Factors Associated with COVID-19 Illness Outcomes in a Tertiary Hospital in Saudi Arabia.

Mohammad Aljabr1, Areej Aldossary2, Kanan Alkanani2, Turky Al Zahrani2, Sofian Al Mulhim2, Hatim Kheir2, Assim AlAbdulkader3, Hayat Mushcab4, Yaser Alreshidi2, Nouf Albalawi2, Wedyan Alabdullatif2, Abrar Almarzooq2, Saeed Qahtani2, Jaffar A Al-Tawfiq5.   

Abstract

Introduction: The emergence of the coronavirus disease 2019 (COVID-19) pandemic has significantly impacted the globe. Understanding the association between the population's demographical, clinical risk factors, and outcome of COVID-19 is essential for healthcare providers to develop guidelines and future care plans. This study reports all diagnosed COVID-19 and admitted to Johns Hopkins Aramco Healthcare (JHAH) for hospitalization from March to July 2020.
Methods: This is a retrospective study that presents the demographic, epidemiological, clinical, laboratory, and imaging characteristics of our patients and determines risk factors contributing to their COVID-19 outcome.
Results: The study included 656 patients (53% were male, 60% were older than 50 years of age, 87% were Saudi nationals, 5% pregnant, and 92% non-smokers patients). The source of infection was mostly unknown to the patient or healthcare provider (58%), followed by contact transmission (36%) and travel (5%). In addition, we found that the vast majority of hospitalized patients presented with symptoms (76%) with (90.4%) mild to moderate symptoms and have had stable hospital course during their hospitalization (82.1%). Over fifty percent of the patients had abnormal x-ray upon admission, (4.7%) were intubated, (20.3%) were admitted to an intensive care unit (ICU) or a step-down unit (SDU), and finally (5.3%) were deceased.
Conclusion: The majority of the patients in this study had mild disease, and their outcome was associated with some chronic diseases, most significantly hypertension. However, the study did not demonstrate a statistically significant association between smoking and obesity and COVID-19 outcomes.
© 2022 Aljabr et al.

Entities:  

Keywords:  COVID-19; chronic illness; epidemiology; outcome

Year:  2022        PMID: 35783997      PMCID: PMC9249090          DOI: 10.2147/IJGM.S357676

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  34 in total

1.  Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis.

Authors:  Li Shi; Jie Xu; Wenwei Xiao; Ying Wang; Yuefei Jin; Shuaiyin Chen; Guangcai Duan; Haiyan Yang; Yadong Wang
Journal:  Ann Allergy Asthma Immunol       Date:  2021-02-18       Impact factor: 6.347

2.  New-Onset Diabetes in Covid-19.

Authors:  Francesco Rubino; Stephanie A Amiel; Paul Zimmet; George Alberti; Stefan Bornstein; Robert H Eckel; Geltrude Mingrone; Bernhard Boehm; Mark E Cooper; Zhonglin Chai; Stefano Del Prato; Linong Ji; David Hopkins; William H Herman; Kamlesh Khunti; Jean-Claude Mbanya; Eric Renard
Journal:  N Engl J Med       Date:  2020-06-12       Impact factor: 91.245

3.  The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.

Authors:  Qianwen Zhao; Meng Meng; Rahul Kumar; Yinlian Wu; Jiaofeng Huang; Ningfang Lian; Yunlei Deng; Su Lin
Journal:  J Med Virol       Date:  2020-05-17       Impact factor: 2.327

4.  Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review.

Authors:  Rodrigo B Serafim; Pedro Póvoa; Vicente Souza-Dantas; André C Kalil; Jorge I F Salluh
Journal:  Clin Microbiol Infect       Date:  2020-10-23       Impact factor: 8.067

5.  COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study.

Authors:  Lennard Y W Lee; Jean-Baptiste Cazier; Thomas Starkey; Sarah E W Briggs; Roland Arnold; Vartika Bisht; Stephen Booth; Naomi A Campton; Vinton W T Cheng; Graham Collins; Helen M Curley; Philip Earwaker; Matthew W Fittall; Spyridon Gennatas; Anshita Goel; Simon Hartley; Daniel J Hughes; David Kerr; Alvin J X Lee; Rebecca J Lee; Siow Ming Lee; Hayley Mckenzie; Chris P Middleton; Nirupa Murugaesu; Tom Newsom-Davis; Anna C Olsson-Brown; Claire Palles; Thomas Powles; Emily A Protheroe; Karin Purshouse; Archana Sharma-Oates; Shivan Sivakumar; Ashley J Smith; Oliver Topping; Chris D Turnbull; Csilla Várnai; Adam D M Briggs; Gary Middleton; Rachel Kerr
Journal:  Lancet Oncol       Date:  2020-08-24       Impact factor: 41.316

6.  Can influenza vaccine modify COVID-19 clinical course?

Authors:  Omar Abdelhay Eldanasory; Ali A Rabaan; Jaffar A Al-Tawfiq
Journal:  Travel Med Infect Dis       Date:  2020-09-05       Impact factor: 6.211

7.  Lack of significant association between dyslipidemia and COVID-19 mortality.

Authors:  Haiyan Yang; Hongjie Hou; Xuan Liang; Jie Xu; Yadong Wang
Journal:  J Infect       Date:  2021-03-05       Impact factor: 6.072

8.  Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission.

Authors:  Hannah Peckham; Nina M de Gruijter; Charles Raine; Anna Radziszewska; Coziana Ciurtin; Lucy R Wedderburn; Elizabeth C Rosser; Kate Webb; Claire T Deakin
Journal:  Nat Commun       Date:  2020-12-09       Impact factor: 17.694

9.  Diabetes mellitus increases the risk of hospital mortality in patients with Covid-19: Systematic review with meta-analysis.

Authors:  Larry E Miller; Ruemon Bhattacharyya; Anna L Miller
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.